Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ulinastatin for Coagulation in High Risk OPCAB
NCT01084044Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jan 2010
- Primary completion
- May 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of ulinastatin in coronary artery disease (CAD), sponsored by Yonsei University. Started Jan 2010; status: completed.
02
Drugs
ulinastatin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01084044.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01084044.